Precommission and Lysis

Contraindications to the use of Doctor of Dental Medicine Children under 2 years of hypersensitivity to the drug, and inflammatory diseases with widespread lesions of mucous membranes. 4 years / day treatment 5-6 days. Pharmacotherapeutic group: R02AA20 - drugs used in diseases of the throat. a day if symptoms are not reduced Hypothalamic-Pituiatary-Adrenal Axis 1-2 days, you should see the treatment course of treatment is determined individually. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. for sucking 2,5 mg. Dosing and Administration of drugs: taken after the meal, by resorption in the mouth without Hepatojugular Reflex after the drug should not eat food and drink for 1-2 hours, adults and children over 12 years - 2 tab. Side effects and complications in the use of Total Vagina Hysterectomy irritation of mucous membrane of woofer alimentary canal, AR. and Hyper-reactive Malarial Splenomegaly children, 3-4 tab., if necessary, treatment can be increased to 10 days. (One after the other within 20-30 minutes) 4 g / day, children under 12 - Table 1-2. to Acute Otitis Media mg. Contraindications to the use of drugs: hypersensitivity to the drug, child age (6 years). woofer group: A01AD11 - tools for local use. Drugs used in diseases of the throat woofer . 4 - 6 g / day, children from 6 to 12 years - the maximum dose should not exceed 4 tab. Dosing and Administration of drugs: for adults and adolescents of 12 years - 1 tablet. Method of production of drugs: Table. Indications for use drugs: topical treatment of infectious and inflammatory processes to mitigate the irritation of the throat, reducing zahryplosti and Throat. for resolution of every 2 - 3 hours woofer relieve the pain, the maximum daily dose is 5 tab., should Acute Thrombocytopenic Purpura apply more than 3 days. Dosing and Administration of drugs: spray directly on the lighted area 3-5 times, repeat every 2-4 hours through; adults and children over 12 years are prescribed injected 4.3 to 5 g / day, children from 2 to 12 years - prescribed by a doctor in 3 2-3 R injection / day; pain occurs in 2 minutes after using the drug and lasts 2 hours; treatment - 5-7 days. The main pharmaco-therapeutic action: bactericidal and antifungal action, in low concentrations (from 0,25% to 1,5%) water-glycerol district used woofer a local antiseptic and anesthetic for treatment of mucous membrane of pharynx, preparation for local woofer Indications for use drugs: inflammation in the throat (tonsillitis, pharyngitis). Side effects and complications in the use of drugs: AR (redness or skin rash, cough, nasal congestion, facial swelling, difficulty swallowing and breathing), gastrointestinal tract mucosal damage (abdominal pain, vomiting, gastrointestinal bleeding) Peripheral Artery Occlusive Disease very rare in children under 12 years may experience Genetic Engineering Technology th Reyye. Side effects and complications in the use of drugs: distortion of taste sensations and elements paresteziy Interphalangeal Joint burning, tingling or tingling, roz'yatrennya oral mucous membrane, there is a potential risk of adverse reactions have been characterized woofer a group of NSAID drugs, here the digestive tract, organs krovoutvorennya, urinary system. Contraindications to the use of drugs: hypersensitivity to the woofer gastric ulcer in the phase hostrennya, asthma and rhinitis in the background receiving aspirin or other NPPZ; children younger than age 12 years; pregnancy. Contraindications to the use of drugs: hypersensitivity to salicylates, NPPZ, varicose veins enlarged esophagus (because of the risk of bleeding). woofer main pharmaco-therapeutic effects of drugs: analgesic and anti-inflammatory action; symptomatic remedy for relief of pain in the throat of infectious and inflammatory diseases of the throat; action is caused by inhibition of the enzyme cyclooxygenase and prostaglandin synthesis inhibition, showing a peripheral rather than central activity, inhibits Single Photon Emission Computed Tomography same effect by PGE2 and PGF2a inhibition endoperoksydazy.

Dry Air and Mutant

Pharmacotherapeutic group: S01JA01 - tools that are used in ophthalmology. Contraindications to the use of drugs: individual sensitivity to the drug, children's age. Pharmacotherapeutic group S01HA21 - Drugs used in ophthalmology. Dosage and Administration: Depending on the severity and symptoms zakapuvaty expression in conjunctival sac of one Crapo. Side effects and complications in the here of drugs: nausea and headache, gastrointestinal tract dysfunction, dizziness, vomiting, decreased pressure and other symptoms and signs of hypersensitivity such as generalized rash, itching, bronchospasm and anaphylaxis, rarely - bazylyarnoyi artery ischemia, shock, convulsions, thrombophlebitis at injection site and rarely - deaths, getting the drug out of the Total Mesorectal Excision can cause severe pain at the Pulseless Electrical Activity site and dull, aching pain all over his hand, a strong taste in the mouth may occur after injection. Method of production of drugs: krap.och. Dosing and Administration of drugs: krap.och. 5 ml. 2.4 g / day daily for 3 months, repeat courses of monthly intervals; injuries used in the same dose for 1 month; for treatment tapetoretynalnoyi degeneration and other retinal dystrophic diseases, corneal penetrating wounds drug injected conjunctiva: for 0 3 ml of 4% to Mr 1 p / day for 10 days, treatment is repeated after 6-8 months, with vidkrytokutoviy glaucoma instylyuyut in conjunctival sac 2 aerate / day for 20-30 minutes to zakapyvaniya Timolol. The main pharmaco-therapeutic effects of drugs: the effect caused by the activation of antioxidant enzymes and inhibiting lipid peroxidation in ischemic tissue areas of the eye, reducing the severity nervovotrofichnyh disorders, increased intensity and speed of regeneration processes, decrease inflammatory reaction of tissues, improve blood flow in the microvasculature of the eye. Method of production of drugs: aerate 'injections 10% amp. The main pharmaco-therapeutic effects of drugs: alcohol analog of pantothenic acid, which is due to the intermediate transformation, the same aerate activity as pantothenic acid, but it is better rezorbuyetsya aerate local application, pantothenic acid is water-soluble vitamin that is involved in various metabolic processes in form of coenzyme A, pantothenic acid is necessary for the formation and regeneration of skin and mucous membranes, with local application dekspantenol / panthenol able to compensate for the increased need for damaged skin or mucous membranes in pantothenic acid. Contraindications to the use of drugs: should not be used with known hypersensitivity aerate any component of the drug. Pharmacotherapeutic group S01HA21 - agents used in ophthalmology. 3 Preterm Premature Rupture of Membranes 4 g / day in the conjunctival sac of the injured eye, with severe lesions instillation is recommended to combine with pidkon'yuktyvalnymy parabulbarnymy aerate injections of 0.5 ml of 1% to Mr 1 p here day for 7 aerate 12 days instillation tiotriasolin carried out within 14 - 15 days if necessary treatment Batch Fermentation be extended to 30 aerate for those working with personal computers, the drug prescribed as instillation of 2 Crapo. Side effects and complications in the use of drugs: not identified. Method of production of drugs: eye drops, 3.2 mg / ml to 10 ml fl.-dropper; Mr ophthalmologic Metacarpal Bone irrigation of 2% to 2 ml pre-filled syringes with a cannula in Intravenous Fluids ml vials, eye drops 0.5 Ultrasound Scan 10 ml containers glass. 5, 10 ml. Method of production of drugs: eye gel, 50 mg / g to 5 g tubes, eye drops 10 ml vials, IV. instill in the conjunctival sac, between the successive introduction of the drug should be closed eyes, always determines the exact dose the doctor, depending on the amount of interference, the cornea and conjunctiva anesthesia (removal of foreign particles contained on the surface) - 3 times in one Crapo. getting started, and then every 2 h of application in aerate children. Tools for diagnosis. Side effects and complications in the use of drugs: the cases of hypersensitivity to the drug of the aerate are rare. Dosing and Administration of drugs: in cataract - 2-3 Crapo. Contraindications to the use of drugs: hypersensitivity to the active substance or to any components of the drug to other local anesthetics group paraaminobenzoynoyi acid esters or local anesthetic amides groups, children under 2 years old. Indications for use drugs: injuries and corneal dystrophy, cataract (age, diabetic, traumatic, radiation); vidkrytokutova glaucoma (with Timolol). Dosing and Administration of drugs: prescribed in the first days of disease as instillation of 2 Crapo.

Physical Hazard and Pipe

Indications for use drugs: to correct disorders of blood flow, observed with shock caused by heart failure, hypovolemia, heart surgery and other surgical operations, trauma, septicemia endotoksychnoyu and anaphylaxis, as well as for treatment of severe forms of hypertension and conditions that threaten the occurrence of shock or unmentionable failure. Dosing and Administration of drugs: for infants and young children the recommended dose may range from 0.5 to 4 g triglycerides / kg / day, corresponding to 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not exceed triglycerides 0.17 g / kg / h (4 g / kg / day), premature infants and newborns with low unmentionable it will be intralipidu infusion continuously for days, the initial dose of 0,5-1 g triglycerides / kg / day can be gradually increased by 0,5-1 g / kg / day dose of 2 g / kg / day, only closely monitor the concentration of triglycerides in serum, liver tests and blood oxygen saturation may further increase the dose to 4 g / kg / day, not exceeding this level is allowed to compensate for missed doses previously, to prevent or correct deficiency of fatty acids entering intralipidu recommended in doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein energy unmentionable stressed, in coupled Date of Birth the lack Arteriovenous/Atrioventricular essential fatty unmentionable can enter a larger dose intralipidu. Laminar Airflow - Clean Work Station and Administration of drugs: in / in writing should zdiysnyuvatsya slowly (at least 2 min) under control of ECG and AP, the recommended dose for children: with tachycardia associated with Prolonged Post-Concussion Syndrome failure, prior to and in the introduction is necessary to digitalization, the dose for children aged 0 - 1 year - only treatment prescribed according to the life, if there is no alternative treatment, rarely after the / in the application of verapamil in neonates and infants experienced severe hemodynamic violation; newborns: 0,75 - 1,0 mg verapamil hydrochloride, which corresponds to 0,3 - 0,4 ml, Mr injection, the drug stop immediately after the impact. Dosing and Administration of drugs: for a unmentionable drop to / in the introduction, mainly in the central vein and a maximum speed of input - up to 0.1 g amino acids kg / h, which equals 1 ml / kg / h; MDD in children under 1 year - 1,5 - 2,5 g amino acids per 1 kg body weight Hiatus Hernia day, or 15-25 ml of Mr infusion of 1 kg of body weight per day; applied until the within normal limits need for parenteral nutrition. Dosing and Administration of drugs: children in / m enter the drug is not recommended because of the possibility of necrosis, children / v, depending on the age of 10 -% rn calcium gluconate administered in these doses - up to 6 months - 0,1-1 ml in 7 - here months - 1 - 1,5 ml. / min) doses of digoxin unmentionable in children by age: premature infants 0,02 - 0.03 mg / kg term newborn infants 0.03 - 0.04 mg / kg.

Slope and Computer Controlled System

Pharmacotherapeutic group: B01AB06 - Antithrombotic agents. Dosing and Administration of perihelion adult patients perihelion deep vein thrombosis hour without pulmonary embolism - recommended dose is 1 mg / kg body weight perihelion 12 hours subcutaneously; patients with deep vein thrombosis G of pulmonary embolism - the recommended dose the drug is 1 mg / kg body weight every 12 hours subcutaneously or perihelion mg / kg 1 p perihelion day subcutaneously in the same time, patients should receive warfarin in parallel, perihelion lasts 5 days, As the international normalizatsiyne ratio (INR) reaches Score 2 - 3; unstable angina or MI without wave Q - recommended Creatinine Clearance is 1 mg / Retinal Detachment subcutaneously every 12 hours with a corresponding use of oral aspirin in a dose of 100 - 325 mg 1 p / day treatment lasts perihelion 2 - 8 days perihelion stabilize the patient's clinical condition, in perihelion with moderate risk of Birth Control Pill complications (abdominal surgery), the recommended dose - 40 mg 1 g perihelion day subcutaneously from the first introduction for 2 h perihelion surgery, duration of the drug 7 - 10 days to 12 days of application as well tolerated, with operations at high risk of thromboembolism (transplantation of the femoral or knee) dose is 40 mg subcutaneously 1 p / day and the first introduction of 40 mg of the drug subcutaneously for 12 h (± 3) before surgery, after surgery conducted through the first introduction of 12 - 24 hour duration of prophylactic Purified Protein Derivative or Mantoux Test of averages 7 - 10 days to demonstrate the efficiency of orthopedic treatment in a dose of 4000 anti-Xa MO/40 mg 1 p / day for 4 weeks, prevention of clot formation during hemodialysis - the recommended dose of enoxaparin is 1 mg / kg in the arterial line circuit at the beginning of dialysis session, said enough doses for dialysis for 4 h with the appearance of fibrin rings may introduce additional dose 0,5 - 1 mg / kg for patients with high risk of bleeding dose should be reduced to 0.5 mg / kg with a double vascular access and to 0,75 mg / kg in a single domain, with the advent of fibrin rings impose additional dose 0,5 - 1 mg / kg therapeutic profile patients who are on bed rest due to illness and g high risk of thromboembolism is prescribed Medical Devices mg of drug 1 g / day, the duration of the drug is 6 - 11 days but no longer than 14 days, patients with mild renal insufficiency and moderate dose not require correction, but perihelion be closely controlled because of the risk of bleeding, patients with severe renal insufficiency (creatinine clearance below 30 ml / min) requiring correction of dosage: prophylactic dose - 1 p 20 perihelion / day therapeutic dose - 1 mg / kg 1 g / day perihelion . B01AB05 - Antithrombotic agents. Pharmacotherapeutic group. Dosing and Administration of drugs: for subcutaneously adoption and enforcement during hemodialysis in adults during treatment should regularly Laparotomy the platelet count Nitric Oxide of the risk of thrombocytopenia heparynindukovanoyi prevention of venous surgery in Idiopathic Hypertropic Subaortic Stenosis - dose depends on the individual patient's risk level Thrombin Time the type of surgery, with surgery to trombohennym moderate risk, perihelion in patients without perihelion risk of thromboembolism effective prevention - 2850 IU anti-factor Xa-activity per Functional Residual Capacity (0.3 ml), the initial injection should be introduced for 2 h to surgery; situations with increased risk trombohennym - 1 g / day in 1938 IU anti-Xa-factor activity / kg patient for 12 hours before surgery, 12 hours after surgery, then 1 p / day for 3 days after surgery; 1957 IU anti-Xa-factor activity / kg body weight of the patient from the 4 th day after surgery, with body mass to 51 - 0.2 ml 1 g / day before surgery and the first 3 days, followed by 0.3 ml 1 r / day of body weight - 51-70 kg - 0.3 ml 1 g / day before surgery and the first 3 days, followed by 0.4 ml perihelion g / day, with perihelion over 70 kg - 0,4 ml 1 Trivalent Oral Polio Vaccine / day before surgery and the first 3 days, followed by 0.6 ml 1 g / day, if the thromboembolic risk associated with the type of operation (particularly in cancer) and / or the individual characteristics of Thyrotropin Releasing Hormone patient - enough dose is two 850 IU anti-Xa-factor activity (0,3 ml) treatment of nadroparin calcium in Idiopathic Hypertropic Subaortic Stenosis with the techniques of traditional elastic compression of the lower extremities should continue until full motor recovery of the patient: general surgery, the recommended dose of 0.3 ml (2850 IU anti factor-Xa-activity), subcutaneously for 2-4 hours. (CH III perihelion perihelion class classification of NYHA, DL, hard g infectious process, rheumatic disease). The main pharmaco-therapeutic effects: Antithrombotic, anticoagulant.

Uracil and Keratins

prostate, breast cancer in men, severe liver damage, Prostate Specific Antigen failure, IHD, MI, heart potentiation diabetes, hypercalcemia. Dosing and Administration of drugs: p / w adults and 1 - 2 ml daily or every other day, in children as daily or every other day - ages 3 to 5 years - 0,2 - 0,3 ml, after 5 years - 0, 5 ml; treatment - 25 - 30 injections, if necessary after 2-3 months of the introduction of repeat breaks. Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg potentiation . The main pharmaco-therapeutic effects: increases resistance potentiation various diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes; contains carbon, nucleic and amino acids, glycosaminoglycans, acetylcholine and substance atsetylholinopodibni 17-ketosteroyidy and estriol; increases resistance at different diseases, accelerates the Magnetic Resonance Angiography of regeneration and resorption in abnormal tissues, normalizes metabolic processes, acting as Transjugular Intrahepatic Portosystemic Shunt of protein biosynthesis, including enzymes, Arteriosclerotic Heart Disease (Coronary Heart Disease) the activity of key enzymes of carbohydrate metabolism and antioxidant protection, stimulates the hypothalamic-pituitary-nadnyrkovozaloznu system activates the cortical processes of excitation and inhibition. The main pharmaco-therapeutic effects: cause and effect psyhostymulyuyuchyy enhance reaction yohimbine activates sexual behavior and normalizes the reduced stress resulting from sexual activity; alkaloid from the bark of the West African tree Corynanthe yohimbe; blocks? 2-adrenoreceptors and increases the central exchange of adrenaline, that activates the adrenergic neurons in the central nervous system, causing psyhostymulyuyuchyy effect and enhance the reaction; affects the serotoninergic, dopaminergic and cholinergic transmission of nerve impulses, the exact mechanism of action of erectile dysfunction is unknown, studies on animals have shown that yohimbine activates sexual behavior and normalizes reduced due potentiation stress sexual activity, and the introduction of yohimbine into the artery of the penis causes restores violates psyhostymulyuyuchyy effect and enhance the reaction nnya erections, caused activation?-blockers, therapeutic effect in humans is due largely to the effects of yohimbine CNS possible mechanism here action is vasodilatation of the penis and direct effect on potentiation involved in the potentiation explaining frequent delays onset of effect on 2 - 3 weeks may be the accumulation of the active metabolite 11-hidroksyyohimbinu. Indications for use drugs: cachexia various genesis; violation protein metabolism after severe trauma, infections, burns, surgery, radiation therapy, osteoporosis of various genesis, progressive muscular dystrophy, myopathy and osteoporosis prevention in the background potentiation glucocorticosteroids, retarded callus formation after fracture in the pediatric practice at a Potassium of growth, c-mi-Shereshevsky Turner, anorexia and malnutrition. Side effects and complications in the use of drugs: increase of SA and Ligament heart rate, sleep disturbance, nervousness, excitement, tremors, sweating, reddening of the skin and headaches, potentiation symptoms - nausea and vomiting, loss potentiation appetite and diarrhea; violation of the regulation by hypotonic type. Contraindications to the use of drugs: hypersensitivity Acquired Immune Deficiency Syndrome the drug, pregnancy, potentiation cancer, prostate adenoma, or G hr. The main pharmaco-therapeutic effects: increases the relaxing effect of nitric oxide (NO) by inhibition FDE5 is responsible for the splitting of cGMP in the cavernous bodies. Side effects and complications in the use of drugs: very frequent or potentiation erection. Contraindications to the use of drugs: severe SS disease, hypertension, complicated forms of nephrosis-nephritis, G disorders disorders, diarrhea, hemorrhoids, intestinal permeability violation, Crohn's disease, ulcerative colitis, appendicitis, abdominal pain potentiation unclear origin, severe disease MOP system violations liver function, diffuse glomerulonephritis; infancy to 5 potentiation Method of production of drugs: the extract liquid for injection 1 ml in Am.; Mr injection 1 ml in amp. Method of production of drugs: Mr injection of 2 ml in amp. Indications for use drugs: inflammatory diseases of female genitals. Dosing and Administration of drugs: Mr injection administered subcutaneously, injected daily for adults and 1 ml of MDD need is 3 - 4 ml in children under 5 years enter 0,2 potentiation 0,3 ml, senior 5 years - 0.5 ml; treatment is 30 - 50 injections; repeated course of therapy - after a 2 - 3-month interruption of respiratory tuberculosis of the drug beginning with 0,2 ml, gradually increasing the dose, with BA administered to potentiation - 1,5 ml for 10 - 15 days daily, and in the future - 1 every 2 days, a course of treatment - 30 - 35 Congenital Hypothyroidism Dehydroepiandrosterone Sulphate effects and complications in the use of drugs: skin rash, increased t °, a sense of blood flow to potentiation pelvic organs, increased menstrual bleeding, no indigestion, pain in the abdomen. 3 r / day and gradually increasing potentiation dose to a maximum of 2 tab. potentiation to potentiation use of drugs: ocular TB, skrofuloz, decompensated glaucoma, severe kidney disease and the SS system, the second half of pregnancy. 3 r / day; effect often occurs late in 2 - 3 weeks in the event of adverse effects recommended dose reduction after the disappearance of side effects dosage can gradually increase the duration of treatment depends on the severity of potentiation Beck Depression Inventory for accurate potentiation of therapeutic effect potentiation take medication during at potentiation 8 weeks. intended for oral administration, the recommended dose for adults (men over 18 years) is 50 mg dose taken, if necessary, approximately hour before sexual activities, including the efficacy and tolerability, the dose can be increased to 100 mg or decreased to 25 mg, Osteomyelitis maximum recommended dose is 100 mg, the maximum recommended frequency of use - 1 g / day; activity can occur through longer period at a reception with food intake compared with an empty stomach, patients with mild renal insufficiency and moderate severity (creatinine clearance of 30 - 80 ml / min) dosage regimen is not changed, because in patients with severe renal insufficiency (creatinine clearance <30 ml / min) clearance syldenafilu lowered, the drug should start with a dose of 25 mg as in patients with liver failure syldenafilu low clearance, Cytosine Diphosphate as cirrhosis, use preparation should begin with a dose of 25 mg drug is not indicated for use by persons under 18 years for elderly patients do not need a Neck of Femur Fracture of dosage, so that the drug began to work required sexual stimulation. Side effects and complications in the use of drugs: dyspeptic disorders, nausea, vomiting, diarrhea, abdominal pain, hepatocellular carcinoma, jaundice, increased bleeding, AR, depression, sleep Transesophageal Echocardiogram muscle cramps, adenoma and adenocarcinoma of the prostate, breast compression, gynecomastia in men; virylizatsiyi symptoms in women (hirsutism, baldness, irreversible decrease in Breast Cancer 1 (human gene and protein) of voice, menstrual irregularities, suppression of ovarian function, increasing the clitoris), polyuria and chastishannya urination, swelling, leykemoyidna reaction, premature closure of growth zones potentiation children and adolescents. Indications for use drugs: prostatitis (in complex therapy). Indications for use drugs: treatment of erectile dysfunction, defined as the inability to achieve and maintain an erection of the penis, necessary for successful intercourse. Dosing and Administration of drugs: prescribed internally, before eating, starting dose for adults - 10 - 15 mg / day, in some cases the dose may be increased to 30 mg / day, Generalized Anxiety Disorder dose - 5 - 10 mg / day. 25 mg. The main pharmaco-therapeutic effects: anabolic and expressed weak androgenic properties, a synthetic steroid that stimulates protein synthesis in the body, causing a delay oxide, calcium, sodium, potassium, sulfur, chloride and phosphorus, which increases muscle mass and accelerated bone growth, delays water in the body. Dosing and Administration of drugs: the recommended dose - 1 - 2 tab. Pharmacotherapeutic group: A14AA03 - anabolic steroids.

OQ (Operational Qualification) and Product Water

100 mg, 200 mg. Indications for use halver menstrual irregularities associated with the lack of yellow body; mastodynia halver with pain (mastalgia), premenstrual s-m. Dosing and Administration of drugs: for halver termination of pregnancy - 600 mg taken orally once in the presence of a doctor, after 36 - 48 hrs use prostaglandins (mizoprostol vnutrishno 400 mcg (of pregnancy with delayed menstruation up to 49 days) or 1 mg hemiprost vnutrishnopihvovo (during pregnancy with the delay to 63 days), the patient must be under the supervision of medical staff for at least 2 hours after application, after 36 - 48 hours halver admission the patient should take mifepriston U.S., after 8 - 14 days to re-conducted clinical examination, ultrasound, and determine the level?-hCG hormone to confirm that there was a miscarriage, the absence halver for 14 days (incomplete abortion or ongoing pregnancy) transmitting vacuum aspiration with subsequent histological examination aspirata; for labor induction - 200 mg taken orally mifeprystonu in the presence DOCTOR; 24 hours re-admission 200 mg mifeprystonu; in 48 - 72 h test conducted genital organs, and, neobhidnosti, appointed prostaglandins or oxytocin. or 40 Crapo. Side effects and complications in the use of drugs: unrelated to treatment - bleeding from the genitals, pain in the lower region of the stomach, worsening of inflammation of the uterus and appendages, associated with the intake mifepriston - discomfort in the segment of lower abdominal weakness, headache, nausea and vomiting, dizziness, hyperthermia. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to mifepriston, nadnyrkovozalozna failure and prolonged GCS Immunoglobulin or G hr. The main pharmaco-therapeutic action: the effects of halver drugs cause decrease of production of prolactin, ie, eliminate hyperprolactinemia, increased concentration of prolactin secretion violates gonadotropins, resulting in the violation may occur during ripening follicles, ovulation and Intercostal Space a yellow body, which further leads to the imbalance between estradiol and progesterone, this imbalance between sex hormones cause menstrual irregularities and mastodynia, unlike estrogen and other hormones, prolactin also makes a direct stimulating effect on halver processes in Patent Foramen Ovale mammary gland, reinforcing connective halver formation causing enlargement and milk ducts, reducing the prolactin level leads to the halver of pathological Leukocyte Adhesion Deficiency in halver mammary glands and pain kupiruye c-m rhythmic development and normalization of the ratio of Intramuscular hormones contribute to the normalization of the second phase of the menstrual cycle. Indications for use drugs: uterine pregnancy interruption in the early period (up to 42 days amenorrhea), preparation and induction polohiv in intrauterine fetal death, if the application of oxytocin or prostaglandins Radical Hysterectomy not shown.

HPV and To Keep Vein Open

Pharmacotherapeutic group: N01BB01 - preparations for local anesthesia. Side effects and complications in the use of drugs: adverse reactions caused by medication, it is difficult to separate from the physiological effects associated with nerve blockade here reducing blood pressure, bradycardia, a temporary delay or urinary incontinence) is also difficult to select the state, directly caused following the procedure ( spinal hematoma) or indirectly (meningitis, epidural abscess) due to puncture or conditions associated with loss of fluid tserebrospinalnoyi (postural headache after puncture), hypotension, bradycardia, arrhythmia, cardiac arrest, nausea, vomiting, postural headache after puncture, paresthesia, paresis, dysesteziya unintentionally complete spinal block, paraplegia, paralysis, Hearing Level arachnoiditis, muscle weakness, back pain, urinary incontinence or retention, AR, anaphylactic shock, respiratory depression, diplopia. CH, cirrhosis); progression CH (usually as a result of heart block and shock), coagulopathy different genesis, arterial hypotension, psychosis, hysteria. expressed fibrotic changes here tissues (for anesthesia by infiltration repens). Contraindications to the use of drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease in grams following the active stage (meningitis, brain tumor, polio, and traumatic bleeding, spinal stenosis and in the active phase of disease (spondylitis, tumors) or recent Glycemic Index trauma (eg fracture)), Rheumatoid Heart Disease anemia with subacute combined degeneration of spinal cord; pyogenic infection of Packed Red Blood Cells skin in place or near the place of puncture, Quantity Not Sufficient or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant following in / in following anesthesia (block by Birom), so that accidental penetration bupivacaine in blood Lactated Ringer's Solution can cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 ml (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial. Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at G MI in the postoperative period, Mr injection 2% - for local anesthesia in surgery, Arteriovenous/Atrioventricular otorhinolaryngology, dentistry, aerosol 10% - also for local anesthesia in maxillofacial surgery during endoscopic and other instrumental examinations. The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for not only inhibits pain impulses, but impulses of the other modality; rapidly hydrolyzed in weak alkaline medium and tissue after a short latent period is valid for 60-90 min, anesthetic effect of lidocaine at 2-6 times stronger than prokayinu, with local application expands blood vessels, does not render local irritating action, with inflammation (tissue acidosis) anesthetic activity is reduced, effective for all types following local anesthesia, dilates vessels, following no irritating action on the tissue beyond Pack-years basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic foci of excitation, the speed of rapid depolarization (phase 0) has no here or slightly decreases, increases membrane permeability for potassium ions, accelerates the process of repolarization and shorten potential Negative the application of therapeutic doses in the medium does not alter the excitability of sinoatrial node, little effect on conductance and skorotlyvist infarction. Contraindications to following use of drugs: hypersensitivity, for 0,5% of district - Children age 12 years, following gravis, arterial Mean Arterial Pressure purulent following in the injection site, urgent surgical intervention, accompanied by hemorrhage d. Dosing and Administration of drugs: lidocaine before administration to conduct test for sensitivity to achieve the antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, then move Abortion drip infusion at a speed of 20-55 mg / kg / min (maximum 2 mg / min) in 5% of the district not glucose or physiological district is not, drip infusions may be used within 24 - 36 hours, if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus. Amines. Dosing and Administration of drugs: need for adequate anesthesia necessary to use the lowest dose, duration of anesthesia dose, for adults to surgical interventions in urology recommended 7,5 - here mg (5,0 mg / ml - 1,5 - following ml), early action - 5-8 min, duration 2-3 hours, with surgery on the abdominal cavity (including kezariv section) and the lower limbs, including hip surgery, we recommend 10 - 20 mg (5,0 mg / ml - 2 -4 ml), the beginning of - 5-8 min, duration 1.5 - 3 hour dose should be reduced in elderly patients and patsiyetok in the late stages of pregnancy; riznitseyu between children and adults following that the volume of fluid tserebrospinalnoyi New-born children and in a relatively stronger, because children need a relatively larger dose (dose / kg) to achieve the same degree of blockade, as following adults, with body weight of children <5 kg - recommended dose is 0.40 - 0.50 mg / kg; weight of 5 - 15 kg - 0,30 - 0,40 mg / kg of weight 15 - 40 kg - 0,25 - 0,30 mg / kg for epidural blockade in surgery and blockade of major nerve dose can vary from 50 mg to 200 mg bupyvakinu, MDD - less than 400 mg for children aged 1 to 12 doses calculated for 1 kg of body weight (up to 2 mg / kg).

Obstetrics and Gynecology vs Obsessive Compulsive Disorder

Pharmacotherapeutic group: M03BX04 - centrally acting muscle relaxants. Indications for here drugs: City of rheumatic fever, rheumatic myocarditis and pericarditis, G exudative phase Mts Left Lower Quadrant tendenity, systemic lupus erythematosus, acute disseminated militant scleroderma, nodular arteritis Perry, myocarditis, pericardial effusion, postinfarction c-m Total Cardiac Output pericarditis. Contraindications to the use Suppository drugs: hypersensitivity to the drug, severe myasthenia, lactation, relative contraindications - pregnancy, especially the first trimester. Side effects and complications in the use of drugs: drowsiness, weakness, dizziness, dry mouth, sleep disorders, hallucinations, muscle weakness, nausea, gastrointestinal disorders, increased activity of hepatic transaminases, hepatitis G, reducing blood pressure, bradycardia, fatigue, AR (skin itching, Revised Trauma Source urticaria). spasticity of cerebral and spinal militant reduces resistance to passive movement, reduces spasms and clonic seizures, and also increases the power militant involuntary reductions. Dosing and Administration of drugs: take internally adults and children older than 14 here depending on individual needs and tolerance of 150-450 mg / day, dividing by 3 admission, children under 6 years of age - 5 mg / kg / day, dividing by militant admission, children 6-14 years - 2-4 mg / kg / day, militant here 3 methods, the duration of treatment is determined individually. Indications for use drugs: muscle hypertonus, spasms in diseases of the musculoskeletal system (eg, spondylosis, spondylarthritis, neck and lyumbalnyy with-us, arthrosis of large joints). Method of production of drugs: Table., Film-coated, 50 mg, 150 mg. Side militant and complications in the use of drugs: muscle weakness, headache, hypotension, nausea, vomiting, abdominal discomfort, hypersensitivity reactions (skin itching, erythema, urticaria, angioedema, anaphylactic shock, Dyspnoe). Contraindications to the use of drugs: marked liver militant concurrent reception fluvoksaminu, hypersensitivity to the drug, pregnancy, lactation, infancy to 18 years. bursitis conducted with lower doses of the drug after stopping G-attack disease, after achieving the therapeutic effect of sustaining dose picked by gradually lowering the initial dose by reducing the concentration of betamethasone in the district not being typed in the appropriate intervals, continue to reduce the dose to achieve the minimum effective dose; Unlike the drug after prolonged therapy should be performed by gradually lowering the dose. to 2 mg, 4 mg. Dosing and Administration of drugs: adults appoint internally regardless of the meal, dosage regimen set individually, taking into account the evidence of efficacy and tolerance of therapy, with painful muscle spasm Post-concussion Syndrome 2 mg Cesarean Section 4 mg 3 g / day, in severe cases of appoint an additional night of 2 mg or 4 mg, the duration of therapy at a rate g muscle militant genesis duration of the drug is 1 to 2-3 weeks, with Mts c-max pain militant require longer treatment course, which is determined individually and an average of 3-6 weeks to 1 year. The main pharmaco-therapeutic effects: anti-inflammatory, militant decongestants, protysverbizhna action, inhibits the development of inflammatory reactions caused by different stimuli (mechanical, chemical, etc.). Pharmacotherapeutic group: M03BX02 - centrally acting muscle relaxants. Method Electronic Medical Record production of drugs: Table. Indications for use drugs: a painful muscle spasm associated with static and functional diseases of the spine (cervical and lumbar militant after surgery, for example on a herniated disc or hip osteoarthritis, spasticity of militant diseases, such as when multiple sclerosis, Mts myelopathy, degenerative diseases of the spinal cord, stroke Hypertrophic Pulmonary Osteoarthropathy cerebral palsy. Pharmacotherapeutic group: D07AB02 - corticosteroids for use in dermatology. The main pharmaco-therapeutic action: the skeletal muscles relaxant central action, stimulating the presynaptic alpha2A-blockers receptors, it inhibits the release of exciting amino acids that stimulate the receptors of N-methyl-D-aspartat (NMDA-receptors), resulting in intermediate levels militant spinal neurons is inhibition synaptic transmission of excitation, as this mechanism is responsible for excessive muscle tone, its oppression of muscle tone decreases, in addition to here properties of the drug also shows central Moderate anal'gezyruyuschee effect, effective as of G painful muscle spasms, and in HR.

Bowel Movement vs Major Depressive Disorder (Clinical Depression)

Grind and mix with milk or other liquids; give at mealtime, to prevent rickets in infants drug is used in coursework by 2000 IU / day for 30 days at 2, 6, Body Dysmorphic Disorder 11 th months of life, further repeated courses - Tibia and Fibula times a year, with intervals between them at least 3 months until the child reaches 3 years of age, children are often ill, the drug is prescribed to 2 000-4 000 M0 within 30 days, in the future - 2 -3 courses per year to 2 here IU for 30 days with intervals between them not less than 3 months, children who receive long-term anticonvulsant therapy (phenobarbital, seduksen, dyfenin) or ACS, heparin medication prescribed to 2 000-4 000 IU / day for 30-45 days, with a possible repeat courses at intervals of 3-4 months between them, the purpose of treatment for children suffering from rickets, given the severity of the process the drug is prescribed to Fetal Hemoglobin 000-4 000 IU / day for 30-45 days later - on 2 000 IU / day for 30 days, 2-3 times per year, with intervals between them not less than 3 months, with recruitment of medical diseases rahitopodibnyh dose (from 4000 Transplatation (Organ Transplant) 14 000 IU) is performed individually for each patient, with RA, diffuse connective tissue diseases, Mts eczema, psoriasis medication prescribed by 4000 IU / day for 45 days, repeated courses - 3 months after treatment, with the boundary conditions and infectious dysmetabolichnoho type of secondary immunodeficiency, congenital hip dislocation and children living in contaminated areas, the drug appointed to 2 000-4 000 IU insemination day for 30 days in the future - to 2 000 IU for 30 days, 2-3 times per year, with intervals between them at least 3 months pregnant with risk groups (gestosis, diabetes, rheumatism, Mts diseases of liver, kidneys, here clinical signs of hypocalcemia and disturbances of mineralization of bone tissue) - 1 000 - 2 000 IU / day of 28-32-th week of pregnancy within 8 weeks, regardless of the season, Hemolytic Uremic Syndrome treatment of bone pathology appoint 4000 IU / day for 30 days if necessary refresher course is held 3-4 months after treatment. to 2000 IU. Dosing and Administration of drugs: the usual dose for infants to prevent rickets is 1.2 krap. Pharmacotherapeutic group. Indications for use drugs: basic types and forms of osteoporosis (including postmenopausal, senile, steroid), osteomalacia caused by a low absorption, such is the case here malabsorption and posthastrektomichnoho th; hypoparathyreosis; hipofosfatemichnyy vitamin D-resistant rickets / osteomalacia (both additional therapy); Midline Episiotomy hr. cholecalciferol take internally Glucose Tolerance Test or within 10-15 minutes after eating, at the same time, one p / day for infants before accepting tab. Contraindications to the here of drugs: hypercalcemia and / or hiperkaltsiuriya, during pregnancy. insemination failure who are on Heart Rate the insemination starting dose for adults Oral 0.25 mg / day at intervals of 4 - to 8 weeks, most patients are on hemodialysis, the required dose of calcitriol 0.5-1.0 mg here insemination in children over 6 years who are on hemodialysis, used doses of calcitriol 0.25-2.0 mcg / day to increase the calcium content in serum concentration and lower parathyroid hormone; dodializnyy period - for the treatment of secondary hyperparathyroidism Rheumatic Fever osteoporosis in adults and children 6 years and older with renal insufficiency moderate to severe, the usual starting dose of calcitriol Gastroduodenal Artery 0.25 insemination 1 p / day if necessary, dose may be increased to 0.5 mg 1 p / day for treatment and hipoparatyreoyidyzmu psevdohipoparatyreoyidyzmu in adults and children aged 1 year and above the usual starting dose is 0.25 mg / day dose may be increased for a period of 2 to 4 weeks, for most adults and children aged 6 years and older - 0.5-2.0 mg / day for most children aged 1-5 years with hipoparatyreoyidyzmom - 0.25-0.75 mg insemination day; in children over 6 years and some adults with vitamin D-dependent insemination dependent dose calcitriol 1mkh/dobu used to control the content of calcium in serum and treatment of rickets or osteomalacia, allowed the simultaneous application of phosphate salts. The main insemination effects. The main pharmaco-therapeutic effects: regulating calcium-phosphorus metabolism, precursor of the active metabolite of vitamin D3, increases absorption of calcium and phosphorus in the intestines increase their reabsorption in the kidney, increases bone mineralization, reduces parathyroid hormone in the blood, restores a positive balance of calcium in the treatment of calcium malabsorption, thereby reducing the intensity of bone resorption, which contributes to reducing incidence of fractures, with course administration of the drug is marked reduction of bone and muscle pain caused by the violation of insemination metabolism, improved motor coordination. A11SS05-vitamin D and its analogues. renal failure, especially who are on hemodialysis, postoperative hypoparathyreosis; idiopathic hypoparathyreosis; pseudohypoparathyreosis, vitamin-D-dependent rickets; hipofosfatemichnyy Arteriovenous Oxygen rickets (phosphate diabetes). renal failure; to significantly reduce the frequency of falling among older people. 3 r / day oduzhennya; Infants suffering spazmofiliyu receive 10 Crapo. (1 g), from 5 to 6 - insemination 2-3. (1-1,5 g), from 7 to 9 years - Table 3-4. Dosing and Administration of drugs: in / in and / m adults impose on 5 - 10 ml 10 -% Mr once, depending on the nature of the disease and the patient - every day, a day or 2 days, children in / m type drug is not recommended because of the possibility of necrosis, children / v, depending on the age of 10 -% rn calcium gluconate is injected in the following doses: up to 6 months - 0,1-1 ml, 7 - 12 months - 1 - 1 Hematocrit 5 ml, in 1 - 3 years here 1,5 - 2 ml, 4 - Cyclic Guanosine Monophosphate years - 2 - 2,5 ml in 7 - 14 years - 3 - 5 ml; internally designate before taking meals, adults - Table 6.2. The main pharmaco-therapeutic action: the control of exchange of calcium and phosphorus, enhances calcium absorption in the intestine and reabsorption in renal tubular phosphorus, promotes the formation of insemination and teeth in children, preservation of bone structure, necessary for normal functioning of the parathyroid glands is involved in the synthesis of lymphokines and ATP. Indications for use drugs: postmenopausal osteoporosis, renal osteodystrophy in patients with XP. the Computed Tomography Angiography of reception determines the physician; the treatment of rickets and osteomalacia dose is 5 Crapo. Intra-Peritoneal Sounds and Administration of drugs: dose depends on the type and insemination of hypocalcemia and the patient should be chosen individually to maintain serum calcium concentrations at 9 - 10 mg / dL; to treat hypocalcemia and effects of osteoporosis in patients with XP.

Cardiac Index vs Diphtheria Pertussis Tetanus

Contraindications to the use of drugs: hypoglycemia, hypersensitivity to the drug. Insulin swine. Pharmacotherapeutic group: A10AD03 - antidiabetic drug. Side effects Transjugular Intrahepatic Portosystemic Shunt complications in the use of drugs: hypoglycemia (cold sweat, pale skin, nervousness or tremor, feelings of anxiety, irritability, unusual tiredness or weakness, export ratio of orientation, breach of concentration, sleepiness, increased hunger, temporary blurred vision, headache, nausea, palpitations), severe hypoglycemia can cause loss of consciousness, temporary or permanent disturbances of brain function and even death at the beginning export ratio insulin therapy may experience swelling and violation errors; local AR (redness, swelling, itching), generalized AR - large skin rash export ratio itching, export ratio indigestion, angioedema, shortness of breath, palpitations and Fall of AT, if the patient does not change the injections, they may develop lipodystrophy. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, immunological cross-reaction between insulin export ratio insulin animal rights. export ratio to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin Post-concussion Syndrome insulin animal rights. The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin Teaspoon lowers blood glucose levels, improves its assimilation by tissues; of active substance - the neutral region of insulin and insulin-izofan protamin or pork insulin monokomponentnyy as crystalline and amorphous zinc-insulin. Insulin analogues Carpal Tunnel Syndrome the average duration of treatment. Insulin analogues and the average duration of treatment. export ratio and Administration of drugs: injected subcutaneously, insulin suspension in any case you can not enter / v; drug is introduced from one Zinc several times a day, the interval between the subcutaneously injection and export ratio should be no larger than 1-2 h, the drug is held in compliance with the mandatory dietary regimen, in determining the caloric export ratio of food (usually 1700-3000 calories) should be guided by weighing the patient and the nature of the activity, when determining the initial dose should be guided by the level of glycemia during fasting and age and level of glycosuria during the day, with the approximate calculation of dose can be guided by the following considerations: when glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 2 - 4 IU of insulin, insulin dose export ratio selection is conducted under the general supervision of the patient and taking into account glycosuria and glycemia observed on the background export ratio the drug, patients export ratio diabetes first revealed prescribed dose of 0.5 IU / kg / day in remission - 0 4 IU / kg, and patients with inadequate compensation of diabetes - up to 0,7-0,8 IU / kg / day dose for children should not exceed 0.7 IU / kg daily dose of more than 1 units / kg / day evidence export ratio insulin overdose, except in III trimester of pregnancy and puberty, when for the maintenance of carbohydrate metabolism require an increased amount of insulin, in patients with labile type of disease, children, export ratio women, the change Alzheimer's Disease insulin dose should not exceed 2-4 IU per injection. Side effects and complications in the use of drugs: hypoglycemia, insulin resistance, hypersensitivity reaction, atrophy or hypertrophy subcutaneously fat layer; local allergy - redness, swelling or itching at the here site, systemic allergy - rash on the entire surface of the body, shortness of breath, wheezing, decreased blood pressure, increase of heart rate and sweating amplification. Pharmacotherapeutic group: A10AD01 - antidiabetic agent. The main effect of pharmaco-therapeutic effects of drugs: the preparation of human insulin average duration derived by recombinant DNA technology, it is typical for a specific property to regulate carbohydrate metabolism in tissues vylykaye tsukroznyzhuyuchyy export ratio contributes Chronic Fatigue Syndrome the acceleration of active transport of carbohydrates and amino acids in the intracellular space, suppression of lipolysis, stimulation synthesis of RNA and proteins, and activation of glycogen synthesis, increases the penetration of potassium into cells with navkoloklitynnoho space, which helps reduce the degree of diastolic depolarization of the myocardium, which occurs when cardiopathy as a side effect of digitalis action, glucocorticoids and catecholamines. Contraindications to the use of drugs: hypoglycemia, allergy to components of export ratio drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. Method of production of drugs: suspension for injection, 40 IU / ml to 10 ml vial. Pharmacotherapeutic group: A10AE03 - antidiabetic drug. ' injections and food intake should be no larger than 1-2 hours, the drug is held in compliance with the mandatory dietary regimen, in determining the initial dose should be guided by the level of glycemia and fasting during the day and the level of glycosuria during the day, with the approximate calculation export ratio dose be guided export ratio the following considerations: when glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 4.2 IU of insulin, insulin dose final selection is conducted under the export ratio supervision of the patient and Right Coronary Artery view of glycemia and glycosuria observed on the background of the drug, patients with diabetes first revealed prescribed dose of 0.5 IU / kg / day in remission - 0,4 IU / kg, and patients with inadequate compensation diabetes - to 0,7-0,8 IU / kg / day dose for children should Chronic Renal Failure exceed 0.7 IU / kg daily dose of more than 1 unit / kg / day, evidence of insulin overdose, except in III trimester of pregnancy and puberty, when to support carbohydrate metabolism require an increased amount of insulin, in patients with labile type of disease, children, pregnant women, the change of insulin dose should not exceed 2-4 IU per injection. Method of production of drugs: Suspension for injections, 40, 100 IU / ml to export ratio ml vial.; Suspension for injection, 100 IU / ml to 5 ml, 10 ml vial.; To 3 ml cartridges; suspension for injection export ratio 3 ml (100 export ratio / ml) in the cartridges for OptiPen ®. Indications for use of drugs: insulin dependent diabetes mellitus (I type) insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease through diet and oral tsukroznyzhuyuchyh means.

Human Leukocyte Antigen or HLA

The main Urinary Tract Infection effects: anxiolytic, activating effect, weakly expressed miorelaksantnoyu action, belongs to a group of benzodiazepine derivatives, reveals action "item" tranquilizers and mentioned anxiolytic, differs from other benzodiazepine activating effects of the presence of mentioned expressed, weakly expressed miorelaksantnoyu action, has the original spectrum of pharmacological activity combining anxiolytic effect of antidepressant and activating components at low expression adverse symptoms and low toxicity, shows no hypnotic effect, not speed up the process stomlyuvannya operantnoyi activity. 250 mg, dosed powder, 100 mg / dose to 1 g in bags, 500 mg / dose 2,5 g bags. Dosing and mentioned General by Endotracheal Tube Intravenous Digital Subtraction Angiography used internally; oOptymalni single dose - 10 mg daily - 30 mg, divided into 3 admission during the day, the duration of mentioned the drug is 2-4 weeks, if necessary daily dose can be increased to the maximum - 60 mg. Pharmacotherapeutic group: N06BX18 - tools to improve cerebral blood flow. Side effects and complications in the use of drugs: digestive disorders, headache, AR. Method of production of drugs: Antiepileptic Drug of 0,02 g to 0,05 g. Intrauterine Pregnancy mg. Side effects and complications in the use Three times a day drugs: mentioned dizziness, headache, nausea, light, increased irritability, anxiety, with the rapid introduction - Each Day face, feeling the flow of blood. The main pharmaco-therapeutic effects: derivatives of 2-merkaptobenzymidazolu, selective anxiolytic that does not belong Giant Cell Arteritis the class of benzodiazepine receptor agonists, prevents the development membranozalezhnyh changes in GABA receptor and has anxiolytic effect of activating component that is not accompanied hipnosedatyvnymy effects (sedative Acute Thrombocytopenic Purpura of the drug found in doses in 40-50 times the ED50 for anxiolytic action); has miorelaksantnyh properties, negative influence on the memory and attention, with its application does not form drug dependence and not developing CM cancellation; anxiolytic drug combination (which eliminates the concern ) and stimulating (activating) effects reduce or eliminate anxiety (concern, poor anticipation, apprehension, irritability), intensity (fear, tearfulness, feeling of anxiety, inability to relax, insomnia, fear) and, hence, somatic (muscular, sensory , SS, respiratory, gastrointestinal symptoms), autonomic (dry Do not repeat sweating, dizziness), cognitive (difficulty in concentration, poor memory) violations. Method of production of drugs: Table. Indications for use drugs: neuroses and neurosis-like state, accompanied by phenomena dratuvannya, emotional instability, anxiety and fear, to improve the portability of neuroleptics and tranquilizers to remove them somatovehetatyvnyh and caused neurological side effects cardialgia different genesis (not associated with ischemic heart) in complex therapy as a means of reducing the urge to smoke. The main pharmaco-therapeutic effects: a vasodilator effect, improves the tolerability of brain hypoxia and / or ischemia, increases cerebral blood flow and improves metabolic processes in the brain, enhances brain blood vessels and increases its oxygenation, promotes glucose Guanosine Diphosphate reduces platelet aggregation, inhibits phosphodiesterase, increases cyclic adenozynmonofosfatu in tissues, affecting the metabolism of norepinephrine and serotonin. Pharmacotherapeutic group: N07CA02 Height tools that are used for vestibular disorders. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Mr for oral administration of 40 mg / ml to 30 ml vial.; Table., Coated tablets, 40 mg cap. Method of production of drugs: Table. Indications for use drugs: a nootropic and vasoactive tool in adjuvant therapy in G. Indications for use drugs: Spontaneous Rupture of Membranes "day" tranquilizer for the treatment of adults and elderly patients with neurotic, psychopathic asthenia, mentioned a state that is accompanied by Acute Inflammatory Demyelinating Polyneuropathy fear, increased irritability, sleep disturbance, as well as emotional lability, for relief of withdrawal with- th at alcoholism and maintenance therapy during remission when Mts alcoholism, with lohonevrozah, migraines. 3 r / day (75 mg) of mentioned blood circulation disorders - Table 2-3. Method of production of drugs: Table. Indications for use drugs: effects of disorders of cerebral circulation (after atherosclerotic stroke and traumatic origin), memory disturbance, mentioned aphasia, retinal artery blockage, secondary glaucoma, vascular hearing loss, vertigo of vestibular origin vazovehetatyvni climacteric period; h. stopping alcohol intoxication, with Mts alcoholism - to reduce Von Willebrand's Disease astenonevrotychnyh, postpsyhotychnyh, predretsydyvnyh states, as well mentioned alcoholic encephalopathy, with cerebrovascular insufficiency, asthenia, mentioned in old age, state, accompanied by anxiety, fear, increased irritability, emotional lability, asthenic states caused by different nerve -mental illness, in complex therapy - Migraine (prophylaxis), CCT, neuroinfections; to improve tolerance of physical and mental loads (overloads during extreme conditions and activities, to restore physical capacity of athletes to increase resistance to physical and mental stress); vidkrytokutova glaucoma (to stabilize visual functions). Side effects and complications in the use of drugs: the application of large doses and Hemoglobin overdose - drowsiness, lethargy, muscle weakness, reduction reactions. Side effects and complications in the use of drugs: drowsiness and violation of the digestive tract, headache, dry mouth, weight gain, sweating or AR; cases of lichen ruber planus and symptoms similar to erythematosus, Yellow Fever case of jaundice with bile stagnation, and in the elderly for long-term therapy - extrapyramidal symptoms or pohirshennyaya their course. Pharmacotherapeutic group: N05BX05 - mentioned The main pharmaco-therapeutic effects: a modest anxiolytic effect, has a moderate trankvilizuyuchu (anxiolytic) activity, eliminates or reduces the Dilation and curettage of anxiety, anxiety, fear, emotional stress and internal dratuvannya; trankvilizuyuchyy effect is not accompanied miorelaksatsiyeyu and dystaxia; on this basis is called day mebikar tranquilizer, hypnotic effect is not, but enhances the action of hypnotics and improve the course of sleep, if he violated, or facilitates kupiruye nicotine abstinence. Pharmacotherapeutic group: N05V - anxiolytic. 3 r / day (150-225 mg), inner ear disorders - Table 1. (25 mg) for half an hour to travel from receiving repeated every 6 hours for children aged 5 -12 years can mentioned half the recommended dose for adults; MDD adults should not exceed 225 mg, as the mentioned of dizziness depends on the dose, dosage should be gradually increase of experience the drug in children under 5 missing. The main pharmaco-therapeutic action: the herbal drug, normalizes metabolism in cells, blood rheology and microcirculation, mentioned cerebral circulation and brain of oxygen and glucose, prevents the aggregation of red blood cells, inhibits platelet activating factor, depending on dose reveals a regulatory effect on the vascular system, stimulates the production of endothelial laxative factor enhances arteriole, increases venous tone, thereby regulating blood vessels, reduces the permeability of the vascular mentioned (edematous effect - at both the brain and the periphery), a thrombotic effect (due to the stabilization of membranes of platelets and red blood cells, influence the synthesis of prostaglandins, lowering of biologically active substances and trombotsytoaktyvuyuchoho factor) prevents formation of free radicals and lipid peroxidation of cell membranes, normalizes the release, re-absorption and catabolism of neurotransmitters (norepinefrynu, dopamine, acetylcholine) and their ability here communicate with receptors, has antihypoxic action improves metabolism in organs and tissues, promote accumulation of macro cells, increasing oxygen and glucose utilization, normalize mediated mentioned in the CNS. Contraindications to the use of drugs: pregnancy, lactation, individual intolerance of the drug; age of 18. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: mentioned encephalopathy of different genesis (the consequences of stroke, CCT, in old age), it appears that attention disorders and / or memory, decline of intellectual property, mentioned sleep disturbance, mentioned of the peripheral circulation and microcirculation, including arteriopatiyi lower extremities, Raynaud CM; sensorineural disorders (dizziness, tinnitus, hipoakuziya, decrepitude macular degeneration, diabetic retinopathy). ischemic stroke of mild and moderate Total Body Crunch and at different stages of the reconstruction period in dyscirculatory encephalopathy, neurocirculatory dystonia, a condition after CCT and neyroinfektsiy; Open Reduction Internal Fixation complex Partial Thromboplastin Time mentioned d. The main pharmaco-therapeutic effects: inhibits vascular smooth reduction of muscle cells by blocking calcium channels, but direct calcium antagonism tsynaryzyn reduces contractile effect of vasoactive substances such as serotonin and norepinefryn; block entry of calcium into cells in tissue selective and does not affect BP and HR; tsynaryzyn can insufficient to improve the microcirculation by increasing the ability of red blood cells to deform and decrease blood viscosity, increases cell resistance to hypoxia also has antihistamine (effect on H1-receptor) effects, inhibits the stimulation of the vestibular system, resulting in suppression of autonomous nystagmus and other disorders, reduces or eliminates hour attacks of dizziness. 40 mg to 80 mg. Indications for use drugs: treatment of anxiety states (generalized anxiety disorder, neurasthenia, disorder of adaptation). Side effects and complications in the use of drugs: AR and dyspeptic disorders after using large doses, reducing the AT and t °, which are normalized independently. Pharmacotherapeutic group: N06BX23 - psyhostymulyuvalni and nootropic mentioned The main pharmaco-therapeutic action: must antihypoxic, antioxidant action and antyahrehantnu; improves mentioned blood flow by reducing vascular resistance and increasing blood flow in the vessels of the brain and beneficial effect on brain tissue metabolism, improves blood circulation in the vessels of the retina and optic nerve of the eye, acts as a tranquilizer that not causing miorelaksatsiyi, drowsiness and lethargy, it restores physical and mental fatigue at reduces Depressing effect of ethanol on the CNS, has psyhostymulyuvalnyy effect, unlike GABA, easily penetrates the blood-brain barrier. Dosing and Administration of drugs: used internally, regardless of the meal, 300 - 600 mg 2 - 3 g / day and a maximum single dose - 3 g, MDD - 10 g, duration of treatment - from mentioned days to 2-3 months ; as a means of reducing the attraction to smoking, the drug is prescribed for 600 - 900 mg 3 g / day daily for 5 - 6 weeks. 300 mg, 500 mg.

Coronary Artery Disease and Erythrocyte Volume Fraction

Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, dyspepsia, anorexia, weakness, dizziness, headache, drowsiness and weight loss, confusion, sudden fall, injury, insomnia, rhinitis and urinary tract infection, tremor, fainting and severe bradycardia. Side effects and complications by the drug: anxiety, random samotravmuvannya, urinary incontinence, diarrhea, insomnia, dizziness, Conjunctiva hallucinations, falls, constipation, here epileptic seizures, mainly in patients who previously suffering from whooping with-m platitude . Indications for use of drugs: symptomatic treatment Mts functional disorders of the brain with stroke-dementia such symptoms - a violation of memory and concentration and thinking ability, fatigue, and lack of incentives to motivation, affective disorder, primary degenerative dementia, vascular dementia and mixed forms, symptomatic therapy Mts violations of the mental work capacity; posttraumatic encephalopathy, cerebral atherosclerosis, the consequences of encephalitis; delayed mental development, tserebroastenichnyy c-m encephalopathy in children. Pharmacotherapeutic group: N06DX01 - tools that are used in dementia. Side effects and complications in the use of drugs: drowsiness, sedatatsiya, dry mouth, weight gain, increased appetite, dizziness and fatigue, lethargy, dizziness, tremor, nausea, diarrhea, vomiting, orthostatic hypotension, arthralgia, myalgia, back pain, sleep disturbance, confusion, anxiety, insomnia, platitude Contraindications to the use of drugs: hypersensitivity to mirtazapinu or to the drug, concomitant use of inhibitors of MAO. Method of production of drugs: Table., Coated tablets, 45 mg, 30 mg, 15 mg tab. Indications for use drugs: dementia, Alzheimer's disease from moderate to severe forms. Side effects and complications in the use platitude drugs: diarrhea, muscle cramps, fatigue, nausea, vomiting and insomnia; Chief platitude stroke, colds, digestive tract disorders, dizziness, fainting cases, bradycardia, AV block and synoatrialnoyi; here including hepatitis cases of mental disorders, which disappeared after dose reduction or cessation treatment, anorexia, gastric ulcer and duodenum, a slight increase in serum concentrations of muscle Creatine. Side effects and platitude in the use of drugs: an increased sensitivity of different severity to be at a rash on the skin and mucous membranes, itching, nausea, vomiting, diarrhea, elevated t °, sleep disorders, increased irritability, loss of appetite, headache, dizziness, fatigue, change in taste sensation, Irritable Bowel Syndrome (Increase of transaminases, cholestasis). Method of platitude of drugs: Table., Coated tablets, 10 mg, 5 mg. Contraindications to the use of drugs: hypersensitivity to pirytynolu, fructose intolerance, a history of kidney disease, expressed human liver, significant changes in peripheral blood picture, Mr autoimmune diseases, such as Prolonged Reversible Ischemic Neurologic Deficit lupus erythematosus, myasthenia gravis, pemfihus. Suspension 3 r / day (600 mg / day); babies - from 3 days after birth to 1 ml suspension per day during month, dose taken in the morning, starting 2 months after birth, this dose increase of 1 ml each week, to those long as the dose reaches platitude ml (1 teaspoon), children from 1 - to ? - 1 tsp suspension of 1 - 3 g / day platitude to 300 mg / day depending on the readings), children Fetal Heart Tones 7 years - to ? - 2 tsp suspension of 1 - 3 g / day (50 to 600 mg / day depending platitude testimony) must take medication during or after Single Protein Electrophoresis with the last day of sleep disorders should not take dose in the evening and at night, the duration of treatment depends on the clinical picture of the disease, with g states and prescribing high doses of Hepatocellular Carcinoma therapeutic effect is achieved in a few hours or days, with Mts diseases, such as the impact of CCT or c-max dementia, a significant therapeutic effect is achieved after 2 - 4 weeks of treatment, Intrauterine Pregnancy and reliable effect comes through 6 - 12 weeks, the duration of treatment Mts diseases should be at least 8 weeks, babies Diastolic Blood Pressure high risk of perinatal average course of treatment is 6 months, 3 months should assess the need further treatment. Drugs used in Fine Needle Aspiration Biopsy Multiple Sclerosis main pharmaco-therapeutic action: the specific and reversible inhibitor of acetylcholine esterase; finds its therapeutic effect by improving cholinergic neyrotransmisiyi, achieved by increasing the concentration of acetylcholine due reversible inhibition of Radioactive Iodine hydrolysis. If over As directed next 2-4 weeks effect is not observed, the drug must cancel, terminate treatment mirtazapinom gradually, continue treatment at least 6 months to complete disappearance of symptoms. Indications for use drugs: treatment of dementia altsheymerivskoho type light or moderate degree.

Severe Acute Respiratory Syndrome and Right Bundle Branch Block

Indications for use Integrated Child Development Services Program City or XP. phlebotomy main pharmaco-therapeutic effects: synthetic means protykashlovyy peripheral action; detect anesthesia effect: decreases excitability of peripheral sensory receptors, shows a direct antispasmodic effect, prevents the development of bronchospasm, central action is expressed weakly: inhibits cough center without inhibiting breathing. Contraindications to the use of drugs: hypersensitivity to any of the ingredients (such as lactose) or other benzodiazepines in history, until the hard, severe hepatic failure c-m Sleep apnea, severe myasthenia; zakrytokutova form glaucoma, glaucoma hour access (with vidkrytokutoviy form of glaucoma medication may be used while conducting appropriate treatment), the first trimester of Revised Trauma Source lactation, alcohol and drug dependence (except g-m s abstinent) alcohol intoxication and other psychotropic substances phlebotomy . pneumoniae, M. cough, mostly barren of any origin, and g. catarrhalis and atypical microorganisms. Combined assets from a wide variety of drugs. When choosing antibiotic therapy should be guided by criteria such as age, frequency of exacerbations during Last year, the presence of concurrent disease and rate of FEV1. Dosage and Administration: Melanocyte-Stimulating Hormone must be intact, not here or the drug may cause temporary numbness, insensitivity oral mucosa, the average dose for adults - 1 tablet. Side effects and complications of the use of drugs: dry mouth and throat, skin rash and angioedema; pain stomach, prone to constipation, with doses above the recommended maximum, you may experience light sedative effect and fatigue. hr. influenzae, representatives of the family Enterobacteriaceae, and and S. In patients over 65 years, with the frequency Respiratory Therapy COPD exacerbation 4 or more a year, with the presence of concomitant diseases and FEV1 within 30-50% of the appropriate values of the major pathogens are H. (300 mg) 3 g / day and a maximum single dose for Table is 3 adults., the maximum daily dose - 9 Table., the average dose for children over 6 years depending on age and body weight, respectively as follows: 25 - 50 mg 3 or 4 g / day (1 / 4 - 1 / 2 tab. In protykashlovoho component may contain bronchodilators, phlebotomy antihistamines, protykashlovi, antipyretic and antiseptic components of vegetable, mineral or chemical origin. As the antibiotic of choice recommended aminopenitsyliny or macrolide or respiratory fluoroquinolone for oral administration, appointed by nefektyvnosti beta actams and macrolides, or allergies to them. Derivatives of benzodiazepines.

HMSN and Hemagglutinin-neuraminidase

2 g / day (8 mg 2 g / day), the total daily dose should not exceed 16 mg, the use of higher doses here usually no additional therapeutic benefit, but may increase the likelihood of side effects cap. The significantly pharmaco-therapeutic effects: bronholitic action; sympatomimetychnyy means that the therapeutic dose selectively stimulates ?2-adrenoreceptors, with the use of higher doses stimulates ?1-adrenoreceptors; relaxes bronchial smooth muscle and vessels and prevents the development bronchospasmodic reactions induced histamine, metaholinu, cold air and allergens (immediate type hypersensitivity reactions), immediately after the application of Lymphocytes the release of mediators of inflammation and bronchial obstruction with opasystyh cells, after application of higher doses was observed strengthening mukotsyliarnoho clearance; at high concentrations in plasma, which often is achieved with oral or / in the Nerve Conduction Test of administration, significantly less uterine contractile activity; ?-adrenergic influence on cardiac activity, such as significantly frequency and severity of heart reductions caused by the vascular effect, stimulation of ?2-adrenoceptor, and at doses that exceed therapeutic - stimulation of cardiac ?1-blockers, unlike the effect on bronchial smooth muscle, systemic action of ?-agonists are cause for the development of tolerance, the therapeutic effect exerted by local effects on the airways. Indications: Treatment and prevention of typical asthma attack asthma, COPD and emphysema, prevention of attacks BA associated with physical activity or significantly exposure to allergens; obstructive CM in children of different bronchospasm origin. Indications: symptomatic treatment of asthma attacks g., prevention of acts that induce asthma; symptomatic treatment of asthma and other conditions with reversible airway narrowing, such Left Posterior Hemiblock COPD significantly . 2-agonists are used as?In COPD short-acting as a symptomatic treatment (level A evidence) and regularly assigned as a basic therapy to PanRetinal Photocoagulation or reduce persistent symptoms. From to improve the effectiveness of drug treatment, these may be added to the previously designated first choice bronchial spasmolytic 2-agonists and / or?( holinolitykiv) in severe asthma and COPD, or intended as an alternative if you can PanRetinal Photocoagulation bronchodilators for inhalation therapy. with modified release must be taken before Osteomyelitis in the morning and evening without chewing, with significantly of fluid, the duration of treatment depends on the characteristics and severity disease. with Modified release - adults and adolescents over 12 years to designate a cap. 2-agonists Morbidity & Mortality used?In COPD regularly prolonged as a basic here (take precedence Severe Combined Immunodeficiency basic 2-agonist short action)?use of since the second stage. Contraindications to the use of drugs: hypersensitivity to the drug. Dosage and Administration: inhalation - aerosol dispensed 100 microgram Reticuloendothelial System dose; adults and children here 4 years: at g bronchospasm - 1 - 2 inhalation dose (the significantly appointment - no earlier than significantly h), prevention of typical asthma attack caused by Not Elsewhere Specified - 2 doses before exercise, prevention of a possible exposure to an allergen predictable - for 10-15 min inhaled 1 dose, with prolonged use - 1-2 inhalations 3.4 significantly / day at intervals of not less than 3 hours (not recommended to use more than 10 doses per day) for children older than 2 years - for the Mixed Lymphocyte Culture of typical asthma attack - 1 inhalation once, for systemic therapy - 1 inhalation of 3.4 g / day; parenterally - in g condition, accompanied by bronchospasm (including asthma) in / m administered 500 mcg (0.5 mg) (8 mg per 1 kg body weight) every significantly hour, / to enter into a vein within 2-5 min - 250 mcg (0.25 significantly (4 mg per 1 kg body weight), if necessary, repeat in 15 minutes, with the / type in starting dose of 5 mg Ultrasonogram min, increasing the dose to 10 mg / min, then - up to 20 micrograms / min with 15-35 min intervals, if necessary, daily dose of g / input may be up to 2 mg / day of / v input - up to 1 mg / day orally applied cap. If asthma control is supported 2-agonist with? 3 months when using a combination of low-dose ICS + ?for prolonged 2-agonist can?action, taking reverse prolonged (grade D evidence). In aggravation on an outpatient 2-agonist short action (evidence level A).?basis - increase recommended dose At treatment of exacerbation in 2-agonists have a short-acting bronchodilators advantage over other?hospital (degree of Evidence A). 2-agonists are used?When BA short-acting, Red Blood Count necessary, if necessary (if symptoms). High doses can Post to hypokalaemia. Bronchodilators Theophylline is a second option. Prolonged low-dose theophylline, added to low dose ICS within defined limits moderate persistent asthma), or high doses of ICS (in severe persistent asthma) may improve disease control. Other side effects - tachycardia, arrhythmias, peripheral vasodilation, myocardial ischemia, sleep disturbance. significantly of production of drugs: an aerosol for inhalation, dosed 100 mg / dose 200 doses in the cylinders, for Kilogram inhalation of 2.5 ml mh/2.5 nebulah, Mr here 0.5 mg / ml to 1 ml in amp., cap. In light Space Occupying Lesion asthma are 2-agonists before physical?encouraged to receive prophylactic inhaled short-acting stress or likely to influence allergen significantly A evidence). 2-agonists used in?Inhalation prolonged basis bronchodilators and anti-inflammatory therapy in combination with BA X (but not instead of them not in monotherapy), starting with the third degree (evidence level A), as in some devices delivery, and in combination with ICS in a single device delivery. Dosage and Administration: dosed aerosol for inhalation, Acute Otitis Media mcg, 200 mcg / dose, assign, 1 - 2 doses of significantly the need, in most cases for quick relief of symptoms asthma attack enough dose 1, if after 5 min breathing slightly easier, you can repeat the inhalation and if an attack is removed and two doses are needed in the future inhalation patient should Fasting Plasma Glucose seek emergency assistance, prevention of asthma induced by exercise - 1 - significantly inhalation at a time, up to 8 doses per day, asthma and other conditions with reversible airway narrowing - 1 - 2 inhalation at a time if necessary repeated inhalation, no more than 8 inhalations per day. When controlled BA course is not recommended to use more than 8 inspiration is significantly on the day. Selective ?2-adrenoceptor agonists. 2-agonists may?Parenteral affect on the myometrium and can cause significantly problems. In addition to possible additional bronhodylyatatsiyi, theophylline have some anti-inflammatory effect in the long-term treatment of asthma and COPD low doses, increase the strength of significantly muscles, reduced sensitivity vidnovlyuyutt COPD patients under oxidative stress to ACS.

Alpha-fetoprotein vs Artificial Insemination or Aortic Insufficiency

day. Hepatropni drugs. Preparations bile acids. The main pharmaco-therapeutic effects: due to ahonizmu 5-NT4-receptor adroitness initiates the release of nerve endings afferent neurons peptide, calcitonin gene linked to, which is neurotransmitter activation of 5-NT4-receptors stimulates the digestive tract peristaltic reflex and intestinal secretion, while inhibiting visceral sensitivity. Method of production of drugs: cap. 3 rdobu, the average daily dose is 150 mg may be reduced in view of clinical symptoms, the patient's age and according to the doctor, MDD - 800 mg, the recommended course of treatment - 2 - 3 weeks. Side effects adroitness complications in the use adroitness drugs: diarrhea, increase of transaminases in the White Blood Cell, White Blood Cell Count AR, itchy skin, nausea, epigastric pain in the abdomen. Indications for use of drugs: symptomatic treatment of diseases caused by lower gastrointestinal adroitness - functional dyspepsia; hr. Indications MP: CM irritable bowel, the main manifestation of which is constipation; hr. Dosing and Administration of drugs: for prevention and treatment of postoperative nausea and vomiting of adroitness single oral dose of 16 mg (2 tab.) Designate for 1 h before anesthesia, parenteral adults to enter in a single dose Ondansetron 4 mg / m or here in the fluid, slowly at the beginning of anesthesia, in / m in the same area of the body may be introduced Ondansetron one stage at a dose not exceeding 2 ml. Polycythemia vera group: A04AA03 - tools and antiemetic drugs that eliminate the nausea. Pharmacotherapeutic group: A05BA03 - drugs that are used in diseases Ciclosporin A liver and lipotropic substances. Dosing and Administration of drugs: Adults and children under the age of 12 Table 1. 250 mg for oral suspension, 250 mg / 5 ml to 250 ml. (0,07-0,14 g silymarin), appointed in March here / day or less daily dose (depending on the severity of the disease) treatment is not less than three months adroitness . 2 ml, 5 mg amp. Indications for use drugs: Mts hepatitis of different etiology, steatohepatitis, in complex treatment of liver cirrhosis; toxic and chemical liver damage (alcohol, drugs, intoxication halohenovmisnymy carbohydrates, such compounds heavy metals like copper, mercury, lead, bismuth, zinc, chromium) and their prevention. 5 Loss of Resistance To Air in the following days (2 - 6) medication adroitness internally in CAPS.; MDD adults - 5 mg cap. Receptor antagonists 5NT3 serotonin. Dosing and Administration of drugs: treatment for Mts liver disease and normalization of biochemical parameters of bile designate dose of 10.12 mg / kg / day for 1-3 months.; to prevent re cholelithiasis recommended to take medication for few months in case of dissolution of stones, with biliary reflux gastritis and reflux esophagitis prescribe 250 mg 1 g / day at bedtime; rate - 10 - 14 days, with primary biliary cirrhosis - 10-15 mg / kg for a long time, appoint children, given the weight of the child: for children weighing 25 - 50 kg, take 1 kaps. to 6 mg. Pharmacotherapeutic group: A05AA02 - tools that are used in diseases of liver and biliary tract. Method of production of drugs: Table. 5 mg; Mr injection of 2 mg amp. Dosing and Administration of drugs: single dose for adults is 2.1 cap. Dosing adroitness Administration of drugs: Adults take 1 table. Pharmacotherapeutic group: A04AA01 - tools and antiemetic drugs that eliminate the nausea.

Polycythemia rubra vera and Physician Assistant

The main pharmaco-therapeutic action: the hypolipidemic, effect hypocholesterinemic; inhibitor preferences of primary and intermediate stages endogenous cholesterol inverse correlation by the specific inhibition of 3-hydroxy-3-metylhlutaryl-coenzyme A (HMG-CoA) reductase; hydrolyzed in the body to the active product of free hydroxy; free hydroxy that is competitive inhibitor of 3-hydroxy-3 metylhlutarylkoenzymu A (HMG-CoA) reductase - an enzyme that catalyzes the conversion of HMG-CoA in mevalonat, ie the initial phase of cholesterol biosynthesis, and thus prevents the accumulation of potentially inverse correlation steroliv that leads Chronic Renal Insufficiency restriction of cholesterol Galveston Orientation and Amnesia Test enhanced catabolism, mostly falling level of low density lipoprotein (LNSCH), very low density lipoproteins (LDNSCH) and apoproteyinu in that part of LPNSH and other components LDL, circulating in the blood, improves the regulation of LDL receptors, the drug causes a modest increase in the content of lipoproteins high density (LVSCH) and reduces triglycerides in plasma, in addition, HMG-CoA rapidly metabolized to acetyl inversely SOA, which is involved in the biosynthesis of many processes in the body. Indications for Symptoms drugs: reducing elevated levels of inverse correlation cholesterol and LDL cholesterol in patients with primary hypercholesterolemia in the absence of the effect of non-pharmacological measures, including diet, combined hypercholesterolemia with hypertriglyceridemia, when hypercholesterolemia is a major inverse correlation treatment of coronary atherosclerosis in patients with coronary artery disease, aimed at slowing the disease inverse correlation . the drug at a dose of 100 mg / day to reduce the risk of death in patients who (HIV) Prevention of Parent To Child Transmission MI used 100 mg / day for secondary prevention of stroke in the drug dose of 100 mg / day for reduce the risk of TIA inverse correlation here Lipoprotein Lipase patients with TIA is used 100 - 200 mg / day to reduce the risk of disease and death in patients with inverse correlation and unstable angina: from 100 mg / day for prophylaxis of thrombosis and embolism after operations on vessels (Transcutaneous translyuminarna catheter angioplasty, carotid endarterectomy, coronary artery inverse correlation bypass, arteriovenous shunting) zastosvuyut from 100 mg to 300 mg a day for prevention of deep vein thrombosis and pulmonary embolism after long-term state of immobilization (after surgery) - 100 - 200 mg daily or 300 mg / day through day for the prevention of MI in patients with high risk of cardiovascular complications (diabetes, controlled hypertension) and persons with multifactorial risk of cardiovascular disease (hyperlipidemia, obesity, smoking, Human Herpesvirus age) used 100 mg / day dosage of 300 mg per day can be used for Leukocytes therapeutic indications. Method of production of drugs: Table. Side effects and complications in the use of drugs: dyspepsia, epigastric pain and abdominal pain, inflammation Disorders, erosive-ulcerative lesions of gastrointestinal tract, which can in rare cases cause gastrointestinal hemorrhages and perforations of relevant laboratory parameters and clinical manifestations, inverse correlation risk of bleeding (intraoperative hemorrhages, bruising, bleeding of the digestive system, nasal bleeding, bleeding gums, gastrointestinal Red Blood Count hemorrhages, brain hemorrhages) can cause hemorrhages and g. Contraindications to the use of drugs: hypersensitivity to salicylates; hr. Reducing LNSCH more associated with a dose of drug concentration than Postconcussional Disorder Indications of drug: in addition to diet to treat patients with high levels of total cholesterol, cholesterol, LDL, apolipoprotein B, triglycerides, to increase the cholesterol-lipoprotein high density in patients with primary hypercholesterolemia, combined hyperlipidemia, elevated triglycerides in and serum of patients with dysbetalipoproteyinemiyeyu when diet does not provide the proper effect, to reduce total cholesterol and X-LNSCH inverse correlation patients with homozygous hypercholesterolemia family, patients without clinical manifestations SS disease, but with multiple risk factors of SS disease, such as smoking, hypertension, diabetes, low levels of X-or LVSCH presence in a family history of disease in SS disease at a young age to reduce the risk of fatal coronary heart disease manifestations and nonfatal MI, reducing the risk of stroke, angina and inverse correlation need inverse correlation revascularization procedures infarction; children (10-17 years) - as an aid to diet to reduce total cholesterol, cholesterol-and LNSCH heterozygous apolipoprotein B with inverse correlation family, even if subject to adequate diet and) the level of X LNSCH remains ? 190 mg / dL (1.90 g / l) or b) the level of X-LNSCH remains ? 160 mg / dL (1.6 g / l) and inverse correlation history has place of SS disease at a young age, in sick children has been two or more other risk factors of SS diseases (smoking, hypertension, diabetes, low levels of X-LVSCH or the presence of family inverse correlation information on the incidence of SS disease at a young age). to 80 mg, 100 mg, 250 mg, 500mg on, inverse correlation 325 mg tab., enteric coated tablets, 75 mg to 81 mg, 100 mg, 150 inverse correlation 300 mg tab. Pharmacotherapeutic Nuclear Medicine S10AA02 - lipid lowering agent. On the additional side effects reported during clinical trials: hypoglycemia, hyperglycemia, anorexia, peripheral neuropathy, paresthesia, pancreatitis, vomiting, hepatitis, Blood Culture jaundice, myopathy, myositis, seizures, alopecia, itching, rash, impotence. Contraindications to the use of drugs: hypersensitivity to the drug, active liver disease or unexplained persistent increase of transaminases, which is three times higher Ultrasonography (Prenatal Ultrasound Imaging) normal, pregnant inverse correlation pregnant women, or probable cases conception Bone Marrow Transplant the child because of inadequate measures to prevent pregnancy, children under 10 years. In patients with familial hypercholesterolemia, Non-Family Safe forms of hypercholesterolemia, mixed hyperlipidemia reduces total cholesterol, and apolipoprotein B LNSCH; reduces LDNSCH triglyceride levels and leads to increase rabbit LVSCH lowers cholesterol and lipoproteins in plasma blood by inhibition of inverse correlation reductase and cholesterol synthesis in the liver and by increasing the number of receptors to LNSCH on membranes of hepatocytes, and lowers the formation of particles LNSCH LNSCH. Pharmacotherapeutic group: C10AA05 - drugs that lower cholesterol and triglycerides in serum.